Actively Recruiting
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
Led by University of California, Los Angeles · Updated on 2026-04-22
80
Participants Needed
4
Research Sites
104 weeks
Total Duration
On this page
Sponsors
U
University of California, Los Angeles
Lead Sponsor
U
University of Cincinnati
Collaborating Sponsor
AI-Summary
What this Trial Is About
The present study is an open trial of ketogenic diets for adolescents and young adults (ages 12-21 yrs) in the depressive or mixed phases of bipolar disorder (BD). The investigators aim to determine whether combining standard of care pharmacological treatment for bipolar spectrum disorders with a 16-week ketogenic diet is well-tolerated and associated with improvements in depression, inflammatory and metabolic indicators, and executive functioning over the study period. The experimental treatment in this study is a 16-week full ketogenic diet. Four study sites (UCLA, U Cincinnati, U Colorado and U Pittsburgh) will recruit 80 total youth (20 each) from bipolar specialty clinics. All youth eligible for the ketogenic therapy will be provided with the ketogenic diet and standard of care pharmacological treatment. During the diet therapy youth will be seen by a study child/adolescent psychiatrist at least once a month (and more frequently when needed), with the psychiatrist recommending and providing side effects monitoring and pharmacotherapy as clinically indicated. The youth and caregivers will also meet with an expert dietitian who will coach all youth on maintaining the ketogenic diet (low carbs, high fats, medium protein) and making sure the child is tolerating the diet and getting enough liquid and nutrients, following the practice guidelines of the International Ketogenic Diet Study Group for treating youth. All youth and involved caregivers will also be provided will at least one motivational enhancement session to support them in goal setting and completion of the study elements. Throughout the study the investigators will assess metabolic (e.g., blood ketones, HOMA-IR) and inflammatory indicators (e.g., C-reactive protein), both for safety reasons and to assess correlates of symptomatic change. Independent evaluators will assess youth every month regarding their symptoms (depression, mania, anxiety, psychosis), psychosocial functioning, and quality of life. The investigators anticipate that the pilot will transpire over 24 months and be an important step toward establishing feasibility and acceptability of ketogenic therapy for this population, not only in terms of diet administration and compliance but also for obtaining symptomatic, metabolic and inflammatory measurements.
CONDITIONS
Official Title
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Youth must be ages 12 to 21 years old and speak English
- Youth must be appropriate for outpatient treatment (not a danger to self or others; not acutely psychotic, suicidal or manic; not needing hospitalization)
- Youth must have a current bipolar spectrum disorder diagnosis (bipolar I, II, or other specified bipolar disorder)
- Youth must have active symptoms: recent moderate or higher depression ratings or mixed symptoms without full manic episode
- Participants must meet active symptom criteria at start of ketogenic diet ramp-up phase
- Youth and parents must be willing to participate in psychiatric and dietitian sessions for evaluation and medication management
- Youth under 18 must have at least one English-speaking parent or caregiver consenting and available
- Youth and all legal guardians must agree to participate and make a strong effort to follow study protocol
You will not qualify if you...
- Pregnancy or breastfeeding
- Underweight (BMI below 18.5) or wasting syndrome
- Current or past anorexia nervosa
- Current bulimia or binge eating disorder
- Autism spectrum disorder at level 2 or greater
- Cardiac issues including arrhythmia or cardiovascular/cerebrovascular disease
- Type I or II diabetes
- History of seizures or epilepsy
- History of stroke or cancer
- Unstable respiratory condition
- Severe gastroesophageal reflux disease
- Substance use disorder except mild cannabis or nicotine use
- History of kidney stones or disease
- Diseases involving pancreas, liver, gallbladder, or thyroid
- High cholesterol or triglycerides requiring physician review
- Genetic metabolic disorders affecting ketone production or breakdown
- Use of SGLT-2 inhibitors, insulin, sulfonylureas, or antihypertensive medications like ACE inhibitors, ARBs, spironolactone, or thiazide diuretics
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
UCLA Semel Institute Max Gray Child and Adolescent Mood Disorders Program (CHAMP)
Los Angeles, California, United States, 90024
Actively Recruiting
2
University of Colorado Denver, Anschutz Medical Campus
Aurora, Colorado, United States, 80045
Not Yet Recruiting
3
University of Cincinnati College of Medicine
Cincinnati, Ohio, United States, 45267
Actively Recruiting
4
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States, 15213
Not Yet Recruiting
Research Team
D
David J Miklowitz, Ph.D.
CONTACT
D
Danielle M Denenny, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here